At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 152 enrolled
Drug / intervention
IDP-118 Lotion +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion With Tazorac (Tazarotene) Cream, 0.05% in the Treatment of Plaque Psoriasis
In Brief
A Phase 2 clinical trial evaluating IDP-118 Lotion, Tazorac Cream, and 2 other interventions for Psoriasis. Completed, enrolled 152 participants across 14 sites.
Detailed Summary
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedMay 2016
Primary CompletionNov 2016
Study CompletionDec 2016
TodayJul 2026
First PostedMay 27, 2016
Enrollment StartFeb 1, 2016
Primary CompletionNov 20, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.1 years ago
Interventions
IDP-118 Lotiondrug
Lotion
Tazorac Creamdrug
Cream
IDP-118 Vehicle Lotiondrug
Lotion
IDP-118 Vehicle Creamdrug
Cream